[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fMlZAMBRQLjbwn_uv1eFvs2ybi7OaNmer8mn0RQae01U":8,"$f15g4ElEbpumt8LoEsbQqhCAS5gVW5luV-GuyWjAhmBU":55,"$fHp_IFBgtnn_I2CWTFcSDIUzHIuGo1rlic83j6aNU7E8":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},47402,870193,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","张蓉","长治医学院附属和平医院","肿瘤科","主治医师",6,0,"肝癌药物使用全指导：安全规范的用药细节全公开","","https://ystcdn.venuertc.com/venue/AI/956ca2c4-b092-4a47-99d5-e999ad179158.jpg","\u003Cdiv class=\"liverdrug-material-wrapper\">\n  \u003Cdiv class=\"liverdrug-title-area\">\n    \u003Ch1 id=\"material_title\" class=\"liverdrug-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">肝癌药物使用全指导：安全规范的用药细节全公开\u003C/h1>\n    \u003Cdiv class=\"liverdrug-intro\">\n      \u003Cspan class=\"liverdrug-emoji\">💊\u003C/span>\n      \u003Cspan>\n        说起来，肝癌的药物治疗不仅有口服、注射等多种形式，还涉及靶向药、免疫药和传统化疗药。每种药品的作用、服用方式和注意要点都有很大不同。下面我们会从7个核心方面讲清楚肝癌相关药品在日常使用中的关键细节，避免常见误区，帮家人安全用药。\n      \u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"liverdrug-section\" style=\"background: linear-gradient(90deg, #f8fafb 40%, #f3f6fb 100%);\">\n    \u003Ch2 class=\"liverdrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 服用时间与正确服用方式\u003C/h2>\n    \u003Cp>\n      肝癌治疗涉及多种药品，包括口服的靶向药、免疫调节剂、化疗片剂，以及注射用的单抗、化疗药等。每种药品都有不同的最佳服用时间和方法。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>靶向药\u003C/b>（如索拉非尼、仑伐替尼等）：多数需要在进食后1-2小时或空腹时服用，以减少消化道反应和提升吸收率。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>免疫药注射\u003C/b>：通常由医护人员在医院注射，无需患者自己操作，给予剂量、间隔周期都需严格遵医嘱。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>化疗药口服片\u003C/b>：用水整片吞服，推荐在固定时间服用，尽量与餐饮分开，减少胃肠道负担。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"liverdrug-tip\">\n      正确做法：务必严格按照说明书和医生指导规定的时间服用，切勿自行调整！服药时尽量用温水（200ml左右）送服，避免服用过烫或过冷饮品。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"liverdrug-section\" style=\"background: linear-gradient(90deg, #f8fafb 60%, #eef4fa 100%);\">\n    \u003Ch2 class=\"liverdrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 剂型特点与服用技巧\u003C/h2>\n    \u003Cp>\n      不同剂型对服药方式有特殊要求。例如肠溶片、缓释片、胶囊剂、注射剂等，其服用和保存方式大不同：\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>肠溶片\u003C/b>：不可咀嚼或掰碎，需要整片吞服。不然可能导致药物提前释放，影响疗效或增加副作用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>缓释片或胶囊\u003C/b>：同样禁止掰开或咬破。胶囊内容物暴露空气易失效或刺激口腔黏膜。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>注射剂\u003C/b>：全部由专业人员操作。患者只需配合按时到院，不要自行更改注射部位和间隔时间。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"liverdrug-tip\">\n      正确做法：发现吞咽困难时，需主动寻求医生、药师帮助，切记不可自行掰碎、混入食物服用。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"liverdrug-section\" style=\"background: linear-gradient(90deg, #f7fbf7 60%, #eaf7f3 100%);\">\n    \u003Ch2 class=\"liverdrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 药物相互作用\u003C/h2>\n    \u003Cp>\n      肝癌药品多为复杂合成药物，与其它常见药品（降压药、抗病毒药、抗生素等）有可能发生相互作用。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>典型靶向药\u003C/b>会与某些抗酸药（如奥美拉唑）发生吸收影响，降低药效。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>部分抗病毒药\u003C/b>（如埃替卡韦、替诺福韦）与肝癌药品合用时，需要测肝肾功能，避免不良反应叠加。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>高血压/降糖药等慢病药\u003C/b>：部分肝癌药可能强化或减弱这些药的作用，需加监控。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>中药、保健品\u003C/b>：含有活性成分的中药、补品均有潜在相互作用风险，引起药效波动。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"liverdrug-tip\">\n      需要注意：用药期间如需加用新药或停其他药，请提前咨询医生或药师，切勿自行用药。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"liverdrug-section\" style=\"background: linear-gradient(90deg, #f8fafb 55%, #f4f2fa 100%);\">\n    \u003Ch2 class=\"liverdrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 特殊人群用药调整\u003C/h2>\n    \u003Cp>\n      肝癌药物治疗对于不同人群使用有严格要求。各类患者常见调整点如下：\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>老年患者\u003C/b>：肝功能减弱，易发生药物蓄积，应根据体重、肝肾监测指标严格调整剂量。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>孕妇、哺乳期\u003C/b>：多种靶向药、化疗药属于孕妇禁用药物。若必须用药，需医生评估，切忌自行使用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>肝肾功能减退者\u003C/b>：靶向药、免疫制剂等多经肝肾代谢，必须据医生指导减量或换药。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"liverdrug-tip\">\n      特别提醒：患者应如实告知所有用药史及基础健康状况，不能因怕麻烦隐瞒既往病史。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"liverdrug-section\" style=\"background: linear-gradient(90deg, #f1f8fa 65%, #e7ecfa 100%);\">\n    \u003Ch2 class=\"liverdrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 常见不良反应及处理方式\u003C/h2>\n    \u003Cp>\n      各类肝癌药品常见不良反应不一，患者身边应提前掌握识别与处理办法：\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>靶向药\u003C/b>常出现手足皮肤反应、高血压、腹泻等。研究显示，索拉非尼类药物手足反应发生率约20-50%（Bruix et al., 2017）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>免疫药\u003C/b>以疲劳、皮疹、轻度乏力为主，部分患者会有免疫过度激活导致的甲状腺异常（Finn et al., 2020）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>化疗药\u003C/b>常见恶心呕吐、白细胞减少，需定期查血象，预防感染。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"liverdrug-tip\">\n      正确做法：首次用药期间密切观察身体情况，出现难忍的副作用需立即联系医生。部分轻微症状可对症处理，如发生口腔炎、腹泻等，勿擅自停药。\n    \u003C/p>\n    \u003Cdiv class=\"liverdrug-emoji-block\">⚠️\u003C/div>\n    \u003Cp>\n      严重反应如呼吸困难、剧烈皮疹、剧烈腹泻等，及时就医切勿耽搁！\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"liverdrug-section\" style=\"background: linear-gradient(90deg, #f8f3fa 70%, #f7faf7 100%);\">\n    \u003Ch2 class=\"liverdrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 储存条件与药品有效期\u003C/h2>\n    \u003Cp>\n      比起其它药物，肝癌药品对保存条件要求更高，特别是进口制剂和蛋白类药品：\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>口服药\u003C/b>保持阴凉、干燥，避免潮湿和强光。常规温度不超25℃。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>蛋白/单抗注射剂\u003C/b>需2-8℃冷藏，运输、家庭保存期间不能反复放出冰箱。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>开封后\u003C/b>：多数药品开封后按说明服用，超过建议天数须弃用。混悬液、配好的注射溶液常需24小时内用完。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"liverdrug-tip\">\n      需要注意：药品外包装丢失时，优先保存药品说明书和剩余药，以便及时咨询专业人员。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"liverdrug-section\" style=\"background: linear-gradient(90deg, #eefbf3 70%, #f9fafb 100%);\">\n    \u003Ch2 class=\"liverdrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 漏服与过量处理方法\u003C/h2>\n    \u003Cp>\n      长期服药期间偶然漏服或服药过量时，正确处理方法能减少风险。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\n        \u003Cb>漏服1次\u003C/b>：一般想起来后立即补服（不和下次服药间隔太短），再恢复原用药时程。不建议一次吃两倍剂量。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>漏服时间超过24小时\u003C/b>：跳过该次，下一次按原计划，不要补服。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>服药过量\u003C/b>：如大量服入，必须带药盒或说明书就医，说明过量时间、剂量。部分药品可有解救药，切忌拖延。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"liverdrug-tip\">\n      正确做法：记录每日服药时间，设置闹钟提醒，减少漏服概率。发生过量时及时告知医生服药细节。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"liverdrug-section liverdrug-case-area\" style=\"background: linear-gradient(90deg, #f3f9f6 85%, #f3f8fa 100%);\">\n    \u003Ch2 class=\"liverdrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">典型用药案例分析\u003C/h2>\n    \u003Cdiv class=\"liverdrug-case-wrapper\">\n      \u003Cdiv class=\"liverdrug-case\">\n        \u003Cspan class=\"liverdrug-emoji\">👨🏻‍⚕️\u003C/span>\n        \u003Cb>案例1：\u003C/b>一位55岁男性，治疗期间精准遵循服药时间表，未出现显著药物副作用，疗程顺利完成。\n      \u003C/div>\n      \u003Cdiv class=\"liverdrug-case\">\n        \u003Cspan class=\"liverdrug-emoji\">👩🏻‍⚕️\u003C/span>\n        \u003Cb>案例2：\u003C/b>临床中有患者在服用靶向药时兼用抗酸药物，经药师提醒调整服药间隔，药效得到保障。\n      \u003C/div>\n      \u003Cdiv class=\"liverdrug-case\">\n        \u003Cspan class=\"liverdrug-emoji\">👵🏻\u003C/span>\n        \u003Cb>案例3：\u003C/b>一位老年患者在肝功能减退后使用免疫药，剂量调整后未发生严重不良反应。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"liverdrug-section liverdrug-summary-area\" style=\"background: linear-gradient(90deg, #f7f9f5 40%, #fcfcfa 100%);\">\n    \u003Ch2 class=\"liverdrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">结语与安全建议\u003C/h2>\n    \u003Cp>\n      肝癌药物治疗对安全和规范要求很高，只有掌握正确的用药方法，才能减少副作用和用药风险。反复记住：每个药品的服用时间、剂型和储存细节都要严格遵守，不要相信偏方，也莫随意增减剂量。如遇药品相互作用、不良反应不适，及时咨询专业医生或药师。每一次规范用药，都是对治疗效果的最好保障。\n    \u003C/p>\n    \u003Cdiv class=\"liverdrug-important-highlight\">\n      \u003Cspan class=\"liverdrug-emoji\">📝\u003C/span>\n      \u003Cb>重点回顾：\u003C/b> 靶向药与食物/药物的相互作用需严防、药品储存须规范、出现不良反应或疑问时要第一时间寻求专业帮助。\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"liverdrug-section\" style=\"background: linear-gradient(90deg, #f9fafb 90%, #f5f7f7 100%);\">\n    \u003Ch2 class=\"liverdrug-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Col class=\"liverdrug-ref-list\">\n      \u003Cli>\n        Bruix, J., Qin, S., Merle, P., Granito, A., Huang, Y. H., Bodoky, G., ... & Cheng, A. L. (2017). Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. \u003Ci>Lancet\u003C/i>, 389(10064), 56-66. https://doi.org/10.1016/S0140-6736(16)32453-9\n      \u003C/li>\n      \u003Cli>\n        Finn, R. S., Qin, S., Ikeda, M., Galle, P. R., Ducreux, M., Kim, T. Y., ... & Cheng, A. L. (2020). Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. \u003Ci>New England Journal of Medicine\u003C/i>, 382(20), 1894-1905. https://doi.org/10.1056/NEJMoa1915745\n      \u003C/li>\n      \u003Cli>\n        European Association for the Study of the Liver. (2024). EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. \u003Ci>Journal of Hepatology\u003C/i>, 80(2), 399–467. https://doi.org/10.1016/j.jhep.2023.10.009\n      \u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.liverdrug-material-wrapper {\n  font-family: \"Microsoft YaHei\", Arial, sans-serif;\n  background: #fafbfc;\n  max-width: 800px;\n  margin: 38px auto 45px auto;\n  border-radius: 14px;\n  box-shadow: 0 2px 16px #e8eef8;\n  padding-bottom: 30px;\n  box-sizing: border-box;\n  color: #222;\n}\n.liverdrug-title-area {\n  padding: 36px 42px 15px 42px;\n  background-color: #f2f6fc;\n  border-radius: 14px 14px 0 0;\n  margin-bottom: 20px;\n}\n.liverdrug-title {\n  margin: 0 0 12px 0;\n  font-size: 33px;\n  color: #355574;\n  font-weight: bold;\n  letter-spacing: 1.2px;\n}\n.liverdrug-intro {\n  font-size: 18px;\n  color: #355574;\n  background: #ebf3fa;\n  padding: 12px 16px;\n  border-radius: 9px;\n  display: flex;\n  align-items: center;\n}\n.liverdrug-emoji {\n  font-size: 23px;\n  margin-right: 9px;\n  vertical-align: middle;\n}\n.liverdrug-section {\n  margin: 28px 38px 0 38px;\n  padding: 28px 26px 25px 32px;\n  border-radius: 13px;\n  box-sizing: border-box;\n  box-shadow: 0 0 7px #f1f6f9;\n  min-width: 0;\n}\n.liverdrug-subtitle {\n  margin: 0 0 14px 0;\n  font-size: 22px;\n  font-weight: bold;\n  color: #4478a3;\n  letter-spacing: 0.8px;\n  padding-left: 4px;\n  border-left: 5px solid #b6dfff;\n  background: none;\n  line-height: 1.3;\n}\n.liverdrug-section ul {\n  padding-left: 24px;\n  margin: 14px 0 11px 0;\n}\n.liverdrug-section ul li {\n  padding-bottom: 6px;\n  line-height: 1.85;\n  font-size: 16px;\n}\n.liverdrug-tip {\n  background: #e2f3e9;\n  color: #385337;\n  border-left: 6px solid #7ed7a2;\n  border-radius: 7px;\n  margin-top: 14px;\n  padding: 8px 14px 8px 15px;\n  font-size: 16px;\n}\n.liverdrug-emoji-block {\n  font-size: 23px;\n  margin: 13px 0 0 0;\n}\n.liverdrug-case-area {\n  background: linear-gradient(90deg, #f3f9f6 85%, #f3f8fa 100%);\n}\n.liverdrug-case-wrapper {\n  margin-top: 11px;\n  margin-bottom: 2px;\n}\n.liverdrug-case {\n  background-color: #eff5f8;\n  border-radius: 6px;\n  margin-bottom: 13px;\n  padding: 11px 12px 10px 11px;\n  font-size: 16px;\n  color: #294772;\n  display: flex;\n  align-items: center;\n}\n.liverdrug-case b {\n  color: #3d6495;\n}\n.liverdrug-summary-area {\n  margin-bottom: 25px;\n}\n.liverdrug-important-highlight {\n  background: #fff2b3;\n  border-left: 6px solid #fdc034;\n  border-radius: 8px;\n  font-size: 18px;\n  color: #564712;\n  margin-top: 14px;\n  padding: 12px 15px;\n  line-height: 1.7;\n  display: flex;\n  align-items: center;\n}\n.liverdrug-ref-list {\n  padding-left: 22px;\n  color: #30485c;\n  font-size: 15px;\n  line-height: 1.85;\n}\n.liverdrug-ref-list i {\n  color: #728bae;\n}\n@media (max-width: 700px) {\n  .liverdrug-material-wrapper {\n    max-width: none;\n    margin: 0 0 28px 0;\n    border-radius: 0;\n    padding-bottom: 18px;\n  }\n  .liverdrug-title-area,\n  .liverdrug-section {\n    margin: 0 4vw 14px 4vw;\n    padding: 18px 7vw 14px 7vw;\n    border-radius: 10px;\n  }\n  .liverdrug-title {\n    font-size: 23px;\n  }\n  .liverdrug-subtitle {\n    font-size: 17px;\n    border-left-width: 3px;\n    padding-left: 3px;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"liverdrug-material-wrapper\">\n  \u003Cdiv class=\"liverdrug-title-area\">\n    \u003Ch1 id=\"material_t",518,"2025-07-09 10:41:23","肝癌药物, 靶向药, 免疫药, 用药安全, 药物不良反应","肝癌药物治疗需谨慎，本文涵盖安全用药的关键细节，提供靶向药、免疫药、化疗药的使用指南，助您和家人安全用药！","2025-07-09 21:24:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]